Bausch & Lomb U.K Limited

Bausch & Lomb House, 106 London Road, Kingston-upon-Thames, Surrey, KT2 6TN, UK
Telephone: +44 (0) 1748 82 8864
Summary of Product Characteristics last updated on the eMC: 30/07/2008
SPC Minims Tetracaine Hydrochloride 0.5% w/v

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 30/07/2008 and displayed until Current
Reasons for adding or updating:
  • Change to section 10 date of revision of the text
  • Change to section 4.8 - Undesirable Effects
  • Change to section 4.4 - Special warnings and precautions for Use
Date of revision of text on the SPC:   01-Apr-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



Section 4.4: Move of some statements to section 4.8

Section 4.8: addition of undesirable effects: Corneal disorders such as superficial punctuate keratitis or edema.

Section 10 : update of revision date

Updated on 19/09/2007 and displayed until 30/07/2008
Reasons for adding or updating:
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   12/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

section 10: change in revision of the text
Updated on 03/10/2005 and displayed until 19/09/2007
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
   tetracaine hydrochloride


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk